NCT06132113 2026-05-27DAREONâ„¢-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine CancersBoehringer IngelheimPhase 1 Recruiting55 enrolled